Prostate Cancer - Results from #22140

Targeted therapy in the treatment of castration-resistant prostate cancer - Abstract October 3, 2013

Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody J591 in men with metastatic castration-resistant prostate cancer - Abstract October 3, 2013

Laparoscopic radical prostatectomy monotherapy, a more aggressive yet less invasive option, is oncologically effective in selected men with high-risk prostate cancer having only one D'Amico risk factor: Experience from an Asian tertiary referral center - October 3, 2013

Comprehensive analysis of sexual function outcome in prostate cancer patients after robot-assisted radical prostatectomy - Abstract October 3, 2013

Preoperative predictive model for biochemical recurrence in patients with localized prostate cancer treated with radical prostatectomy - Abstract October 3, 2013

Treatable and untreatable forms of recurrent prostate cancer - Abstract October 3, 2013

Anatomic extent of pelvic lymph node dissection: Impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy - Abstract October 3, 2013

Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial - Abstract October 2, 2013

Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid - Abstract October 2, 2013

Biomarker docetaxel-based chemotherapy - Abstract October 2, 2013

Functional and pharmacodynamic evaluation of metronomic cyclophosphamide and docetaxel regimen in castration-resistant prostate cancer - Abstract October 2, 2013

Genome-wide association studies on prostate cancer: The end or the beginning? - Abstract October 1, 2013

Choice of optimal margins in prostate conformal radiotherapy - Abstract October 1, 2013

Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate - Abstract October 1, 2013

Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination - Abstract October 1, 2013

Adverse effects of androgen deprivation therapy for prostate cancer: Prevention and management - Abstract October 1, 2013

Cryosurgery for prostate cancer: A comprehensive review - Abstract October 1, 2013

A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer prior to radical prostatectomy - Abstract October 1, 2013

Quality of Life in patients with low risk prostate cancer A comparative retrospective study (Brachytherapy vs. Robot Assisted Laparoscopic Prostatectomy vs. Active Surveillance) - Abstract September 30, 2013

Perception of body odor-an overlooked consequence of long-term gastrointestinal and urinary symptoms after radiation therapy for prostate cancer - Abstract September 30, 2013

Page 1108 of 1435